Cancer, a major world public health problem, is associated with chemotherapy treatments
whose administration leads to secondary concerns, such as oral mucositis (OM). The OM …

Re-irradiation is becoming an established treatment option for recurrent or second primary
head and neck cancer (HNC). However, acute and long-term RT-related toxicities could …

Purpose Despite advances in personalizing the efficacy of cancer therapy, our ability to
identify patients at risk of severe treatment side effects and provide individualized supportive …

Importance Oral mucositis (OM) is a common and debilitating adverse effect observed in
patients with head and neck cancer (HNC) receiving radiation therapy (RT). Previous …

Purpose To discuss the role of benzydamine in the prevention and treatment of radiation-
induced oral mucositis (OM) in head and neck (H&N) cancer patients. This document …

In the last decade, human microbiome research is rapidly growing involving several fields of
clinical medicine and population health. Although the microbiome seems to be linked to all …

Simple Summary Head and neck cancer is the seventh-most prevalent cancer worldwide.
Despite advances in treatment, many patients suffer from chemoradiation-induced oral …

During a radiological or nuclear public health emergency, given the heterogeneity of civilian
populations, it is incumbent on medical response planners to understand and prepare for a …

Purpose To establish the early prediction models of radiation-induced oral mucositis (RIOM)
based on baseline CT-based radiomic features (RFs), dosimetric data, and clinical features …

Simple Summary Radiotherapy is the cornerstone of treatment of nasopharyngeal cancer, in
different settings with or without chemotherapy. This role has been recently strengthened by …